Skip to main content
SpringerLink
Log in

Pretransplant Screening for Infection Exposure: Approach to the Patients with Epidemiologic and Geographic Risk Factors

  • Reference work entry
  • First Online:
Emerging Transplant Infections

  • 1116 Accesses

Abstract

Characteristics of transplant candidates can significantly impact risk for infection after transplantation and immunosuppression start. These characteristics include a wide variety of risk factors for potential infection ranging from country of origin and travel history to history of immunosuppression, to certain comorbid conditions, and to diet and occupation. Increased mobility and medical complexity of transplant patients, and the changing epidemiology of pathogen distribution, can complicate the estimation of infection risk. We review here specific risk factors for each type of infection, from bacterial to fungal, viral, and parasitic, with regard to patient risk factors including potential for geographic exposure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 699.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 899.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Malinis M, Boucher HW, Practice ASTIDCo. Screening of donor and candidate prior to solid organ transplantation-guidelines from the American Society of Transplantation infectious diseases community of practice. Clin Transpl. 2019;33:e13548.

    Article  Google Scholar 

  2. Shao M, Wan Q, Xie W, Ye Q. Bloodstream infections among solid organ transplant recipients: epidemiology, microbiology, associated risk factors for morbility and mortality. Transplant Rev (Orlando). 2014;28:176–81.

    Article  Google Scholar 

  3. Slagt IKB, Ijzermans JNM, Alamyar M, Verhagen PCMS, Weimar W, Roodnat JI, Terkivatan T. Long-term outcome of kidney transplantation in patients with a urinary conduit: a case–control study. Int Urol Nephrol. 2013;45:405–11.

    Article  PubMed  Google Scholar 

  4. Lopez Pereira P, Ortiz Rodriguez R, Fernandez Camblor C, Martinez Urrutia MJ, Lobato Romera R, Espinosa L, Jaureguizar ME. Renal transplant outcome in children with an augmented bladder. Front Pediatr. 2013;1:42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ariza-Heredia EJ, Beam EN, Lesnick TG, Kremers WK, Cosio FG, Razonable RR. Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis. Ann Transplant. 2013;18:195–204.

    Article  CAS  PubMed  Google Scholar 

  6. Hara T, Soyama A, Takatsuki M, Hidaka M, Carpenter I, Kinoshita A, Adachi T, Kitasato A, Kuroki T, Eguchi S. The impact of treated bacterial infections within one month before living donor liver transplantation in adults. Ann Transplant. 2014;19:674–9.

    Article  CAS  PubMed  Google Scholar 

  7. Fagiuoli S, Colli A, Bruno R, Craxi A, Gaeta GB, Grossi P, Mondelli MU, Puoti M, Sagnelli E, Stefani S, et al. Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. J Hepatol. 2014;60:1075–89.

    Article  PubMed  Google Scholar 

  8. Kim YJ, Yoon JH, Kim SI, Choi HJ, Choi JY, Yoon SK, You YK, Kim DG. Impact of pretransplant infections on clinical course in liver transplant recipients. Transplant Proc. 2018;50:1153–6.

    Article  CAS  PubMed  Google Scholar 

  9. Lease E, Zaas D. Complex bacterial infections pre- and Posttransplant. Semin Respir Crit Care Med. 2010;31:234–42.

    Article  PubMed  Google Scholar 

  10. Waters V, Atenafu EG, Lu A, Yau Y, Tullis E, Ratjen F. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients. J Cyst Fibros. 2013;12:482–6.

    Article  PubMed  Google Scholar 

  11. Lobo LJ, Tulu Z, Aris RM, Noone PG. Pan-resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia infection in cystic fibrosis does not reduce survival after lung transplantation. Transplantation. 2015;99:2196–202.

    Article  CAS  PubMed  Google Scholar 

  12. Aslam S, Xie R, Cowger J, Kirklin JK, Chu VH, Schueler S, de By T, Gould K, Morrissey O, Lund LH, et al. Bloodstream infections in mechanical circulatory support device recipients in the International Society of Heart and Lung Transplantation mechanically assisted circulation support registry: epidemiology, risk factors, and mortality. J Heart Lung Transplant. 2018;37:1013–20.

    Article  PubMed  Google Scholar 

  13. Rosenfeldt FL, Kwa LJ, Porapakkham P, Rajadurai S, Jones K, van de Merwe J, Billah B, Porapakkham P, Esmore DS, Halvorsen DS, et al. Bacteraemia in ventricular assist devices: a common complication that need not affect clinical outcomes. Heart Lung Circ. 2014;23:234–41.

    Article  PubMed  Google Scholar 

  14. Teoh TK, Hannan MM. Ventricular assist device-associated infection. Infect Dis Clin N Am. 2018;32:827–41.

    Article  Google Scholar 

  15. Kusne S, Mooney M, Danziger-Isakov L, Kaan A, Lund LH, Lyster H, Wieselthaler G, Aslam S, Cagliostro B, Chen J, et al. An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection. J Heart Lung Transplant. 2017;36:1137–53.

    Article  PubMed  Google Scholar 

  16. Koval CE, Stosor V, Practice AICo. Ventricular assist device-related infections and solid organ transplantation-Guidelines from the American Society of Transplantation infectious diseases community of practice. Clin Transpl. 2019;33:e13552.

    Article  Google Scholar 

  17. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, Wingard JR, Young J-AH, Boeckh MA. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15:1143–238.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Sahin U, Toprak SK, Atilla PA, Atilla E, Demirer T. An overview of infectious complications after allogeneic hematopoietic stem cell transplantation. J Infect Chemother. 2016;22:505–14.

    Article  PubMed  Google Scholar 

  19. Linares L, Cervera C, Cofán F, Lizaso D, Marco F, Ricart MJ, Esforzado N, Oppenheimer F, Campistol JM, Moreno A. Risk factors for infection with extended-spectrum and AmpC β-lactamase-producing gram-negative rods in renal transplantation. Am J Transplant. 2008;8:1000–5.

    Article  CAS  PubMed  Google Scholar 

  20. Men TY, Wang JN, Li H, Gu Y, Xing TH, Peng ZH, Zhong L. Prevalence of multidrug-resistant gram-negative bacilli producing extended-spectrum beta-lactamases (ESBLs) and ESBL genes in solid organ transplant recipients. Transpl Infect Dis. 2013;15:14–21.

    Article  CAS  PubMed  Google Scholar 

  21. Satlin MJ, Jenkins SG, Walsh TJ. The global challenge of Carbapenem-resistant enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014;58:1274–83.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Pouch SM, Satlin MJ. Carbapenem-resistant enterobacteriaceae in special populations: solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies. Virulence. 2017;8:391–402.

    Article  CAS  PubMed  Google Scholar 

  23. Lubbert C, Becker-Rux D, Rodloff AC, Laudi S, Busch T, Bartels M, Kaisers UX. Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis. Infection. 2014;42:309–16.

    Article  CAS  PubMed  Google Scholar 

  24. Freire MP, Villela Soares Oshiro IC, Bonazzi PR, Pierrotti LC, de Oliveira LM, Machado AS, Van Der Heijdenn IM, Rossi F, Costa SF, Carneiro D’Albuquerque LA, et al. Surveillance culture for multidrug-resistant gram-negative bacteria: performance in liver transplant recipients. Am J Infect Control. 2017;45:e40–4.

    Article  PubMed  Google Scholar 

  25. Pouch SM, Kubin CJ, Satlin MJ, Tsapepas DS, Lee JR, Dube G, Pereira MR. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients. Transp Infect Dis. 2015;17:800–9.

    Article  CAS  Google Scholar 

  26. Tacconelli E, Mazzaferri F, de Smet AM, Bragantini D, Eggimann P, Huttner BD, Kuijper EJ, Lucet JC, Mutters NT, Sanguinetti M, et al. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant gram-negative bacteria carriers. Clin Microbiol Infect. 2019;25:807–17.

    Article  CAS  PubMed  Google Scholar 

  27. Pouch SM, Patel G, Practice ASTIDCo. Multidrug-resistant gram-negative bacterial infections in solid organ transplant recipients – guidelines from the American Society of Transplantation infectious diseases community of practice. Clin Transpl. 2019;33:e13594.

    Article  Google Scholar 

  28. Nkam L, Lambert J, Latouche A, Bellis G, Burgel PR, Hocine MN. A 3-year prognostic score for adults with cystic fibrosis. J Cyst Fibros. 2017;16:702–8.

    Article  CAS  PubMed  Google Scholar 

  29. Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S, Lederer DJ, Mulligan MJ, Patterson GA, Singer LG, et al. A consensus document for the selection of lung transplant candidates: 2014 – an update from the pulmonary transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2015;34:1–15.

    Article  PubMed  Google Scholar 

  30. Aris RM, Routh J, LiPuma J, Heath D, Gilligan PH. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Am J Respir Crit Care Med. 2001;164:2102–6.

    Article  CAS  PubMed  Google Scholar 

  31. Alexander BD, Petzold EW, Reller LB, Palmer SM, Davis RD, Woods CW, Lipuma JJ. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant. 2008;8:1025–30.

    Article  CAS  PubMed  Google Scholar 

  32. Murray S, Charbeneau J, Marshall BC, LiPuma JJ. Impact of burkholderia infection on lung transplantation in cystic fibrosis. Am J Respir Crit Care Med. 2008;178:363–71.

    Article  PubMed  Google Scholar 

  33. Stephenson AL, Sykes J, Berthiaume Y, Singer LG, Aaron SD, Whitmore GA, Stanojevic S. Clinical and demographic factors associated with post-lung transplantation survival in individuals with cystic fibrosis. J Heart Lung Transplant. 2015;34:1139–45.

    Article  PubMed  Google Scholar 

  34. Koutsokera A, Varughese RA, Sykes J, Orchanian-Cheff A, Shah PS, Chaparro C, Tullis E, Singer LG, Stephenson AL. Pre-transplant factors associated with mortality after lung transplantation in cystic fibrosis: a systematic review and meta-analysis. J Cyst Fibros. 2019;18:407–15.

    Article  PubMed  Google Scholar 

  35. Boussaud V, Guillemain R, Grenet D, Coley N, Souilamas R, Bonnette P, Stern M. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres. Thorax. 2008;63:732–7.

    Article  CAS  PubMed  Google Scholar 

  36. De Soyza A, Meachery G, Hester KL, Nicholson A, Parry G, Tocewicz K, Pillay T, Clark S, Lordan JL, Schueler S, et al. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience. J Heart Lung Transplant. 2010;29:1395–404.

    Article  PubMed  Google Scholar 

  37. Subramanian AK, Theodoropoulos NM, Infectious Diseases Community of Practice of the American Society of T. Mycobacterium tuberculosis infections in solid organ transplantation: guidelines from the infectious diseases community of practice of the American Society of Transplantation. Clin Transpl. 2019;33:e13513.

    Article  Google Scholar 

  38. Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64:111–5.

    Article  PubMed  Google Scholar 

  39. Casas S, Muñoz L, Moure R, Castellote J, Guerra MR, Gonzalez L, Andreu A, Rafecas AG, Alcaide F, Santin M. Comparison of the 2-step tuberculin skin test and the quantiFERON-TB gold in-tube test for the screening of tuberculosis infection before liver transplantation. Liver Transpl. 2011;17:1205–11.

    Article  PubMed  Google Scholar 

  40. Kim SH, Lee SO, Park JB, Park IA, Park SJ, Yun SC, Jung JH, Kim YH, Kim SC, Choi SH, et al. A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients. Am J Transplant. 2011;11:1927–35.

    Article  PubMed  Google Scholar 

  41. Hand J, Sigel K, Huprikar S, Hamula C, Rana M. Tuberculosis after liver transplantation in a large center in New York City: QuantiFERON-TB gold-based pre-transplant screening performance and active tuberculosis post-transplant. Transpl Infect Dis. 2018;20:e12845.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Morales P, Gil A, Santos M. Mycobacterium abscessus infection in transplant recipients. Transplant Proc. 2010;42:3058–60.

    Article  CAS  PubMed  Google Scholar 

  43. Piersimoni C. Nontuberculous mycobacteria infection in solid organ transplant recipients. Eur J Clin Microbiol Infect Dis. 2012;31:397–403.

    Article  CAS  PubMed  Google Scholar 

  44. Malinis M. Management of Mycobacterium Other than tuberculosis in solid organ transplantation. Infect Dis Clin North Am. 2018;32:719–32.

    Article  PubMed  Google Scholar 

  45. Knoll BM. Update on nontuberculous mycobacterial infections in solid organ and hematopoietic stem cell transplant recipients. Curr Infect Dis Rep. 2014;16:421.

    Article  CAS  PubMed  Google Scholar 

  46. Longworth SA, Daly JS, Practice ASTIDCo. Management of infections due to non-tuberculous mycobacteria in transplant recipients – guidelines from the American Society of Transplantation infectious diseases community of practice. Clin Transpl. 2019;33:e13588.

    Article  Google Scholar 

  47. Dupont L. Lung transplantation in cystic fibrosis patients with difficult to treat lung infections. Curr Opin Pulm Med. 2017;23:574–9.

    Article  PubMed  Google Scholar 

  48. Tissot A, Thomas MF, Corris PA, Brodlie M. NonTuberculous mycobacteria infection and lung transplantation in cystic fibrosis: a worldwide survey of clinical practice. BMC Pulm Med. 2018;18:86.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Lobo LJ, Chang LC, Esther CR, Gilligan PH, Tulu Z, Noone PG. Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections. Clin Transpl. 2013;27:523–9.

    Article  Google Scholar 

  50. Qvist T, Pressler T, Thomsen VO, Skov M, Iversen M, Katzenstein TL. Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population. Transp Proc. 2013;45:342–5.

    Article  CAS  Google Scholar 

  51. Osmani M, Sotello D, Alvarez S, Odell JA, Thomas M. Mycobacterium abscessus infections in lung transplant recipients: 15-year experience from a single institution. Transpl Infect Dis. 2017;20:1–8.

    Google Scholar 

  52. Perez A, Singer JP, Schwartz BS, Chin-Hong P, Shah R, Kleinhenz ME, Gao Y, Venado A, Leard L, Golden JA, et al. Management and clinical outcomes after lung transplantation in patients with pre-transplant Mycobacterium abscessus infection: a single center experience. Transpl Infect Dis. 2019;21:1–10.

    Article  Google Scholar 

  53. Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med. 2003;167:828–34.

    Article  PubMed  Google Scholar 

  54. Leung JM, Olivier KN. Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis. Curr Opin Pulm Med. 2013;19:662–9.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Levy I, Grisaru-Soen G, Lerner-Geva L, Kerem E, Blau H, Bentur L, Aviram M, Rivlin J, Picard E, Lavy A, et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis. 2008;14:378–84.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Seddon P, Fidler K, Raman S, Wyatt H, Ruiz G, Elston C, Perrin F, Gyi K, Bilton D, Drobniewski F, et al. Prevalence of nontuberculous mycobacteria in cystic fibrosis clinics, United Kingdom, 2009. Emerg Infect Dis. 2013;19:1128–30.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Chien JY, Lai CC, Sheng WH, Yu CJ, Hsueh PR. Pulmonary infection and colonization with nontuberculous mycobacteria, Taiwan, 2000–2012. Emerg Infect Dis. 2014;20:1382–5.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Yoo JW, Jo KW, Kim SH, Lee SO, Kim JJ, Park SK, Lee JH, Han DJ, Hwang S, Lee S, et al. Incidence, characteristics, and treatment outcomes of mycobacterial diseases in transplant recipients. Transpl Int. 2016;29:549–58.

    Article  PubMed  Google Scholar 

  59. Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, Mitarai S. Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan. Emerg Infect Dis. 2016;22:1116–7.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Morimoto K, Hasegawa N, Izumi K, Namkoong H, Uchimura K, Yoshiyama T, Hoshino Y, Kurashima A, Sokunaga J, Shibuya S, et al. A laboratory-based analysis of nontuberculous mycobacterial lung disease in Japan from 2012 to 2013. Ann Am Thorac Soc. 2017;14:49–56.

    Article  PubMed  Google Scholar 

  61. Prevots DR, Adjemian J, Fernandez AG, Knowles MR, Olivier KN. Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population. Ann Am Thorac Soc. 2014;11:1032–8.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Adjemian J, Olivier KN, Prevots DR. Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk. Am J Respir Crit Care Med. 2014;190:581–6.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Miller R, Assi M, Practice ASTIDCo. Endemic fungal infections in solid organ transplant recipients-guidelines from the American Society of Transplantation infectious diseases community of practice. Clin Transpl. 2019;33:e13553.

    Article  Google Scholar 

  64. Kauffman CA, Freifeld AG, Andes DR, Baddley JW, Herwaldt L, Walker RC, Alexander BD, Anaissie EJ, Benedict K, Ito JI, et al. Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the transplant-associated infection surveillance network (TRANSNET). Transpl Infect Dis. 2014;16:213–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Gajurel K, Dhakal R, Deresinski S. Diagnosis and treatment of histoplasmosis in solid organ transplant patients. Curr Opin Infect Dis. 2018;31:301–8.

    Article  PubMed  Google Scholar 

  66. Assi M, Martin S, Wheat LJ, Hage C, Freifeld A, Avery R, Baddley JW, Vergidis P, Miller R, Andes D, et al. Histoplasmosis after solid organ transplant. Clin Infect Dis. 2013;57:1542–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Grim SA, Proia L, Miller R, Alhyraba M, Costas-Chavarri A, Oberholzer J, Clark NM. A multicenter study of histoplasmosis and blastomycosis after solid organ transplantation. Transpl Infect Dis. 2012;14:17–23.

    Article  CAS  PubMed  Google Scholar 

  68. McDonald R, Dufort E, Jackson BR, Tobin EH, Newman A, Benedict K, Blog D. Blastomycosis cases occurring outside of regions with known endemicity – New York, 2007–2017. Morb Mortal Wkly Rep. 2018;67:1077–8.

    Article  Google Scholar 

  69. Chapman SW, Dismukes WE, Proia LA, Bradsher RW, Pappas PG, Threlkeld MG, Kauffman CA. Infectious diseases Society of a. clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:1801–12.

    Article  CAS  PubMed  Google Scholar 

  70. de Almeida JN, Pecanha-Pietrobom PM Jr, Colombo AL. Paracoccidioidomycosis in immunocompromised patients: a literature review. J Fungi (Basel). 2018;5:2.

    Article  Google Scholar 

  71. Colombo AL, Tobon A, Restrepo A, Queiroz-Telles F, Nucci M. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol. 2011;49:785–98.

    PubMed  Google Scholar 

  72. Fisher MC, Koenig GL, White TJ, Taylor JW. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia. 2002;94:73–84.

    Article  CAS  PubMed  Google Scholar 

  73. Barker BM, Jewell KA, Kroken S, Orbach MJ. The population biology of coccidioides: epidemiologic implications for disease outbreaks. Ann N Y Acad Sci. 2007;1111:147–63.

    Article  CAS  PubMed  Google Scholar 

  74. Teixeira MM, Barker BM. Use of population genetics to assess the ecology, evolution, and population structure of Coccidioides. Emerg Infect Dis. 2016;22:1022–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Coates SJ, Fox LP. Disseminated coccidioidomycosis as a harbinger of climate change. JAAD Case Rep. 2018;4:424–5.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Nguyen C, Barker BM, Hoover S, Nix DE, Ampel NM, Frelinger JA, Orbach MJ, Galgiani JN. Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis. Clin Microbiol Rev. 2013;26:505–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Blair JE. Approach to the solid organ transplant patient with latent infection and disease caused by Coccidioides species. Curr Opin Infect Dis. 2008;21:415–20.

    Article  PubMed  Google Scholar 

  78. Kirkland TN, Fierer J. Coccidioides immitis and posadasii; a review of their biology, genomics, pathogenesis, and host immunity. Virulence. 2018;9:1426–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Stockamp NW, Thompson GR. Coccidioidomycosis. Infect Dis Clin North Am. 2016;30:229–46.

    Article  PubMed  Google Scholar 

  80. Mendoza N, Blair JE. The utility of diagnostic testing for active Coccidioidomycosis in solid organ transplant recipients. Am J Transplant. 2013;13:1034–9.

    Article  CAS  PubMed  Google Scholar 

  81. Kassis C, Zaidi S, Kuberski T, Moran A, Gonzalez O, Hussain S, Hartmann-Manrique C, Al-Jashaami L, Chebbo A, Myers RA, et al. Role of Coccidioides antigen testing in the cerebrospinal fluid for the diagnosis of Coccidioidal meningitis. Clin Infect Dis. 2015;61:1521–6.

    Article  CAS  PubMed  Google Scholar 

  82. Twarog M, Thompson IIIG. Coccidioidomycosis: recent updates. Semin Respir Crit Care Med. 2015;36:746–55.

    Article  PubMed  Google Scholar 

  83. Phonphok K, Beaird O, Duong T, Datta N, Schaenman J, Bunnapradist S. Screening Coccidioides serology in kidney transplant recipients: a 10-year cross-sectional analysis. Transpl Infect Dis. 2018;20:1–8.

    Article  CAS  Google Scholar 

  84. Kahn A, Carey EJ, Blair JE. Universal fungal prophylaxis and risk of coccidioidomycosis in liver transplant recipients living in an endemic area. Liver Transpl. 2015;21:353–61.

    Article  PubMed  Google Scholar 

  85. Chaudhary S, Meinke L, Ateeli H, Knox K, Raz Y, Ampel NM. Coccidioidomycosis among persons undergoing lung transplantation in the coccidioidal endemic region. Transpl Infect Dis. 2017;19:1–6.

    Article  CAS  Google Scholar 

  86. Singh N, Sifri CD, Silveira FP, Miller R, Gregg KS, Huprikar S, Lease ED, Zimmer A, Dummer JS, Spak CW, et al. Cryptococcosis in patients with cirrhosis of the liver and posttransplant outcomes. Transplantation. 2015;99:2132–41.

    Article  PubMed  Google Scholar 

  87. Sifri CD, Sun HY, Cacciarelli TV, Wispelwey B, Pruett TL, Singh N. Pretransplant cryptococcosis and outcome after liver transplantation. Liver Transpl. 2010;16:499–502.

    Article  PubMed  Google Scholar 

  88. Singh N, Husain S, De Vera M, Gayowski T, Cacciarelli TV. Cryptococcus neoformans infection in patients with cirrhosis, including liver transplant candidates. Medicine (Baltimore). 2004;83:188–92.

    Article  Google Scholar 

  89. Hwang SY, Yu SJ, Lee JH, Kim JS, Yoon JW, Kim YJ, Yoon JH, Kim EC, Lee HS. Spontaneous fungal peritonitis: a severe complication in patients with advanced liver cirrhosis. Eur J Clin Microbiol Infect Dis. 2014;33:259–64.

    Article  CAS  PubMed  Google Scholar 

  90. Lin YY, Shiau S, Fang CT. Risk factors for invasive Cryptococcus neoformans diseases: a case-control study. PLoS One. 2015;10:e0119090.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  91. Chaturvedi V, Chaturvedi S. Cryptococcus gattii: a resurgent fungal pathogen. Trends Microbiol. 2011;19:564–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Levinson M. Diseases transmitted by birds. Microbiol Spectr. 2015; 3:IOL5–0004-2015.

    Google Scholar 

  93. Abdala E, Miller R, Pasqualotto AC, Munoz P, Colombo AL, Cuenca-Estrella M. Endemic fungal infection recommendations for solid-organ transplant recipients and donors. Transp J. 2018;102:S52–9.

    Article  Google Scholar 

  94. Baddley JW, Forrest GN, Practice ASTIDCo. Cryptococcosis in solid organ transplantation-guidelines from the American Society of Transplantation infectious diseases community of practice. Clin Transpl. 2019;33:e13543.

    Article  Google Scholar 

  95. Saha DC, Goldman DL, Shao X, Casadevall A, Husain S, Limaye AP, Lyon M, Somani J, Pursell K, Pruett TL, et al. Serologic evidence for reactivation of Cryptococcosis in solid-organ transplant recipients. Clin Vaccine Immunol. 2007;14:1550–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Brunet K, Alanio A, Lortholary O, Rammaert B. Reactivation of dormant/latent fungal infection. J Infect. 2018;77:463–8.

    Article  PubMed  Google Scholar 

  97. Helmi M, Love RB, Welter D, Cornwell RD, Meyer KC. Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients. Chest. 2003;123:800–8.

    Article  PubMed  Google Scholar 

  98. Lemonovich TL. Mold infections in solid organ transplant recipients. Infect Dis Clin North Am. 2018;32:687–701.

    Article  PubMed  Google Scholar 

  99. Husain S, Solé A, Alexander BD, Aslam S, Avery R, Benden C, Billaud EM, Chambers D, Danziger-Isakov L, Fedson S, et al. The 2015 International Society for Heart and Lung Transplantation guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients executive summary. J Heart Lung Transplant. 2016;35:1–87.

    Article  Google Scholar 

  100. Chang A, Musk M, Lavender M, Wrobel J, Yaw M-C, Lawrence S, Chirayath S, Boan P. Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia. Transpl Infect Dis. 2018;21:1–7.

    Google Scholar 

  101. Tracy MC, Moss RB. The myriad challenges of respiratory fungal infection in cystic fibrosis. Pediatr Pulmonol. 2018;53:S75–85.

    Article  PubMed  Google Scholar 

  102. Schwarz C, Hartl D, Eickmeier O, Hector A, Benden C, Durieu I, Sole A, Gartner S, Milla CE, Barry PJ. Progress in definition, prevention and treatment of fungal infections in cystic fibrosis. Mycopathologia. 2018;183:21–32.

    Article  CAS  PubMed  Google Scholar 

  103. Pierrotti LC, Kotton CN. Transplantation in the tropics: lessons on prevention and management of tropical infectious diseases. Curr Infect Dis Rep. 2015;17:492.

    Article  PubMed  Google Scholar 

  104. van de Peppel RJ, Dekkers OM, von dem Borne PA, de Boer MG. Relapsed and secondary disease drive the risk profile for invasive aspergillosis prior to stem cell transplantation in patients with acute myeloid leukemia or myelodysplastic syndrome. Med Mycol. 2014;52:699–705.

    Article  PubMed  CAS  Google Scholar 

  105. Liu YC, Chien SH, Fan NW, Hu MH, Gau JP, Liu CJ, Yu YB, Liu CY, Hsiao LT, Liu JH, et al. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation. J Microbiol Immunol Infect. 2016;49:567–74.

    Article  PubMed  Google Scholar 

  106. Gerull S, Medinger M, Heim D, Passweg J, Stern M. Evaluation of the pretransplantation workup before allogeneic transplantation. Biol Blood Marrow Transplant. 2014;20:1852–6.

    Article  PubMed  Google Scholar 

  107. Clemente WT, Pierrotti LC, Abdala E, Morris MI, Azevedo LS, Lopez-Velez R, Cuenca-Estrella M, Torre-Cisneros J, Petersen E, Camargo LFA, et al. Recommendations for management of endemic diseases and travel medicine in solid-organ transplant recipients and donors: Latin America. Transplantation. 2018;102:193–208.

    Article  PubMed  Google Scholar 

  108. Buchan CA, Kotton CN, Practice ASTIDCo. Travel medicine, transplant tourism, and the solid organ transplant recipient-guidelines from the American Society of Transplantation infectious diseases community of practice. Clin Transpl. 2019;33:e13529.

    Article  Google Scholar 

  109. Camargo LFA, Kamar N, Gotuzzo E, Wright AJ. Schistosomiasis and Strongyloidiasis recommendations for solid-organ transplant recipients and donors. Transplantation. 2018;102:S27–34.

    Article  PubMed  Google Scholar 

  110. Schär F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H, Vounatsou P, Odermatt P. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis. 2013;7:e2288.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Clemente WT, Mourao PHO, Lopez-Medrano F, Schwartz BS, Garcia-Donoso C, Torre-Cisneros J. Visceral and cutaneous Leishmaniasis recommendations for solid organ transplant recipients and donors. Transplantation. 2018;102:S8–S15.

    Article  PubMed  Google Scholar 

  112. La Hoz RM, Morris MI, Infectious Diseases Community of Practice of the American Society of T. Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients- guidelines from the American Society of Transplantation infectious diseases community of practice. Clin Transpl. 2019;33:e13546.

    Google Scholar 

  113. Fernandez-Sabe N, Cervera C, Fariñas MC, Bodro M, Muñoz P, Gurguí M, Torre-Cisneros J, Martin-Davila P, Noblejas A, Len O, et al. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study. Clin Infect Dis. 2012;54:355–61.

    Article  PubMed  Google Scholar 

  114. Baran DA, Alwarshetty M, Alvi S, Arroyo L, Lubitz S, Pinney S, Gass A, Zucker M. Is toxoplasmosis prophylaxis necessary in cardiac transplantation? Long-term follow-up at two transplant Centers. J Heart Lung Transplant. 2006;25:1380–2.

    Article  PubMed  Google Scholar 

  115. Mastrobuoni S, Dell'Aquila AM, Herreros J. Fatal toxoplasma gondii dissemination in a heart transplant recipient: description of a case. Case Rep Transplant. 2012;2012:1–3.

    Article  Google Scholar 

  116. Derouin F, Pelloux H. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 2008;14:1089–101.

    Article  CAS  PubMed  Google Scholar 

  117. Hamadani M, Craig M, Awan FT, Devine SM. How we approach patient evaluation for hematopoietic stem cell transplantation. Bone Marrow Transplant. 2010;45:1259–68.

    Article  CAS  PubMed  Google Scholar 

  118. Locke JE, Durand C, Reed RD, MacLennan PA, Mehta S, Massie A, Nellore A, DuBay D, Segev DL. Long-term outcomes after liver transplantation among human immunodeficiency virus-infected recipients. Transplantation. 2016;100:141–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  119. Kucirka LM, Durand CM, Bae S, Avery RK, Locke JE, Orandi BJ, McAdams-DeMarco M, Grams ME, Segev DL. Induction immunosuppression and clinical outcomes in kidney transplant recipients infected with human immunodeficiency virus. Am J Transplant. 2016;16:2368–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  120. Malat GE, Boyle SM, Jindal RM, Guy S, Xiao G, Harhay MN, Lee DH, Ranganna KM, Anil Kumar MS, Doyle AM. Kidney transplantation in HIV-positive patients: a single-center, 16-year experience. Am J Kidney Dis. 2019;73:112–8.

    Article  PubMed  Google Scholar 

  121. Madan S, Patel SR, Saeed O, Sims DB, Shin JJ, Goldstein DJ, Jorde UP. Outcomes of heart transplantation in patients with human immunodeficiency virus. Am J Transplant. 2019;19:1529–35.

    Article  CAS  PubMed  Google Scholar 

  122. Chen C, Wen X, Yadav A, Belviso N, Kogut S, McCauley J. Outcomes in human immunodeficiency virus-infected recipients of heart transplants. Clin Transpl. 2019;33:e13440.

    Article  CAS  Google Scholar 

  123. Ong S, Levy RD, Yee J, Partovi N, Churg A, Romeo P, Chalaoui J, Nador R, Wright A, Manganas H, et al. Successful lung transplantation in an HIV seropositive patient with desquamative interstitial pneumonia: a case report. BMC Pulm Med. 2018;18:162.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  124. Schillie S, Harris A, Link-Gellis R, Romero J, Ward J, Nelson N. Recommendations of the advisory committee on immunization practices for use of a hepatitis B vaccine with a novel adjuvant. Morb Mortal Wkly Rep. 2018;67:455–8.

    Article  Google Scholar 

  125. Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560–99.

    Article  PubMed  Google Scholar 

  126. Fontaine H, Alric L, Labreuche J, Legendre B, Louvet A, Antoine C, Legendre CM, Hazzan M, Kamar N, Dharancy S, et al. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation. J Hepatol. 2019;70:831–8.

    Article  PubMed  Google Scholar 

  127. Sarmati L, Andreoni M, Antonelli G, Arcese W, Bruno R, Coppola N, Gaeta GB, Galli M, Girmenia C, Mikulska M, et al. Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paper. Clin Microbiol Infect. 2017;23:935–40.

    Article  CAS  PubMed  Google Scholar 

  128. Ankcorn MJ, Ijaz S, Poh J, Elsharkawy AM, Smit E, Cramb R, Ravi S, Martin K, Tedder R, Neuberger J. Toward systematic screening for persistent hepatitis E virus infections in transplant patients. Transplantation. 2018;102:1139–47.

    Article  PubMed  PubMed Central  Google Scholar 

  129. von Wulffen M, Westholter D, Lutgehetmann M, Pischke S. Hepatitis E: still waters run deep. J Clin Transl Hepatol. 2018;6:40–7.

    Google Scholar 

  130. Vangipuram R, Tyring SK. Epidemiology of Kaposi sarcoma: review and description of the nonepidemic variant. Int J Dermatol. 2019;58:538–42.

    Article  PubMed  Google Scholar 

  131. Garcia-Astudillo LA, Leyva-Cobian F. Human herpesvirus-8 infection and Kaposi's sarcoma after liver and kidney transplantation in different geographical areas of Spain. Transpl Immunol. 2006;17:65–9.

    Article  CAS  PubMed  Google Scholar 

  132. Liu Z, Fang Q, Zuo J, Chen Y, Minhas V, Wood C, Zhang T. Global epidemiology of human herpesvirus 8 in men who have sex with men: a systematic review and meta-analysis. J Med Virol. 2018;90:582–91.

    Article  PubMed  Google Scholar 

  133. Andreoni M, Goletti D, Pezzotti P, Pozzetto A, Monini P, Sarmati L, Farchi F, Tisone G, Piazza A, Pisani F, et al. Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. J Infect. 2001;43:195–9.

    Article  CAS  PubMed  Google Scholar 

  134. Charpentier C, Delyon J, Glotz D, Peraldi MN, Rerolle JP, Barrou B, Ducroux E, Coilly A, Legeai C, Barete S, et al. Kaposi sarcoma in HIV-positive solid-organ transplant recipients: a French multicentric national study and literature review. Transplantation. 2019;103:e22–8.

    Article  PubMed  Google Scholar 

  135. Pellett Madan R, Hand J, Practice ASTIDCo. Human herpesvirus 6, 7, and 8 in solid organ transplantation: guidelines from the American Society of Transplantation infectious diseases community of practice. Clin Transpl. 2019;33:e13518.

    Article  Google Scholar 

  136. Armstrong MJ, Corbett C, Rowe IA, Taylor GP, Neuberger JM. HTLV-1 in solid-organ transplantation: current challenges and future management strategies. Transplantation. 2012;94:1075–84.

    Article  PubMed  Google Scholar 

  137. Taylor GP. Human T-lymphotropic virus type 1 infection and solid organ transplantation. Rev Med Virol. 2018;28

    Google Scholar 

  138. Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388.

    Article  PubMed  PubMed Central  Google Scholar 

  139. Kaul DR, Sharma TS, Practice AICo. Human T-cell lymphotrophic virus in solid-organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice. Clin Transpl. 2019;33:e13575.

    Article  Google Scholar 

  140. Rossi S, Ross TM, Evans JD. West Nile virus. Clin Lab Med. 2010;30:47–65.

    Article  PubMed  PubMed Central  Google Scholar 

  141. Anesi JA, Silveira F. Arenaviruses and West Nile virus in solid organ transplant recipients: guidelines from the American Society of Transplantation infectious diseases community of practice. Clin Transpl. 2019;33:e13576.

    Article  Google Scholar 

  142. Nogueira ML, Estofolete CF, Terzian AC, Mascarin do Vale EP, da Silva RC, da Silva RF, Ramalho HJ, Fernandes Charpiot IM, Vasilakis N, Abbud-Filho M. Zika virus infection and solid organ transplantation: a new challenge. Am J Transplant. 2017;17:791–5.

    Article  CAS  PubMed  Google Scholar 

  143. Rosso F, Rodriguez S, Cedano JA, Mora BL, Moncada P, Velez J. Chikungunya in solid organ transplant recipients, a case series and literature review. Transpl Infect Dis. 2018;20:e12978.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, City of Hope, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

    Deepa Nanayakkara

  2. Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

    Joanna Schaenman

Authors
  1. Deepa Nanayakkara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joanna Schaenman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joanna Schaenman .

Editor information

Editors and Affiliations

  1. Immunocompromised Host Service Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, USA

    Michele I. Morris

  2. Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Camille Nelson Kotton

  3. Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA

    Cameron R. Wolfe

Section Editor information

  1. Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, USA

    Michele I. Morris

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Nanayakkara, D., Schaenman, J. (2021). Pretransplant Screening for Infection Exposure: Approach to the Patients with Epidemiologic and Geographic Risk Factors. In: Morris, M.I., Kotton, C.N., Wolfe, C.R. (eds) Emerging Transplant Infections. Springer, Cham. https://doi.org/10.1007/978-3-030-25869-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-25869-6_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-25868-9

  • Online ISBN: 978-3-030-25869-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation